Madhya Bharat Agro Products Q4 FY26 Results: Net Profit Surges 319% to ₹59.76 Crore, FY26 Revenue ₹1,867 Crore (+76%), Dividend ₹0.50/Share Declared

Madhya Bharat Agro Products Limited — one of India’s fastest-growing phosphatic fertilizer manufacturers — delivered a blockbuster Q4 FY26 performance. Standalone net profit surged 319.4% year-on-year to ₹59.76 crore, compared to ₹14.25 crore in Q4 FY25. Revenue from operations grew 32.99% to ₹394.71 crore. The sharp PAT jump, while partly reflecting the low base of Q4 FY25, also demonstrates the strong operating leverage the company has built through capacity expansion and volume scale-up.

For the full financial year FY26, the numbers are equally impressive: revenue reached ₹1,866.98 crore — up 76.3% from ₹1,059.17 crore in FY25 — and net profit grew 161.3% to ₹150.18 crore from ₹57.48 crore. The board recommended a final dividend of ₹0.50 per equity share (5% on face value) for FY26. As of March 31, 2026, the company added 90,000 MTPA of new capacity, taking total capacity to 3,30,000 MTPA — a foundational step toward the ambitious expansion targets that management has set.

Track MBAPL and get fertilizer sector research on Univest.

Madhya Bharat Agro Products Q4 FY26 Financial Results

Source: MBAPL audited financial results, Axis Direct, Screener.in, board outcome filing April 17, 2026.

Growth Drivers: Volume, Capacity, and Subsidy Tailwinds

MBAPL’s revenue growth has been driven by three concurrent forces. First, significant capacity additions — from approximately 1.5 lakh MTPA to 3.3 lakh MTPA over two years — have enabled higher production volumes of SSP (Single Super Phosphate), DAP/NPK complexes, sulphuric acid, and phosphoric acid. Second, the SSP subsidy from the government was increased 42% to ₹7,263 per ton effective April 2025, directly improving price realisation without requiring MBAPL to raise market prices. Third, the commercialisation of NPK production — where EBITDA per ton is approximately ₹6,000 versus ₹2,500 for SSP — has improved product mix economics.

Q4 is typically a seasonally active quarter for fertilizer companies as Rabi crop requirements and channel stocking ahead of the Kharif season drive demand. The Q4 FY26 revenue of ₹394.71 crore, while below Q3’s ₹612.39 crore, reflects normal seasonal patterns — Q3 is typically the peak quarter for this sector.

Screen MBAPL historical financials on Univest Screener.

The Dhule Plant: The Next Growth Catalyst

Madhya Bharat Agro’s most significant medium-term catalyst is the Dhule (Maharashtra) greenfield plant with 3,30,000 TPY DAP/NPK capacity and integrated upstream. The total project cost is approximately ₹550 crore, with commissioning targeted for October 2026. When operational, the Dhule plant will more than double MBAPL’s total capacity and is expected to add over 50% to FY27 revenue. Management has described this guidance as “conservative.” The company commenced an additional 90,000 MTPA capacity at its Sagar facility from March 31, 2026, representing an investment of approximately ₹107 crore — a smaller but immediately productive step.

Conclusion

Madhya Bharat Agro Products’ Q4 FY26 results demonstrate the power of capacity-led growth in a government-supported sector. A 319% PAT jump and 161% full-year PAT growth confirm that the scaling strategy is translating to profits. At a market cap of approximately ₹4,771 crore against FY26 PAT of ₹150 crore, the stock trades at approximately 32x trailing earnings — a premium that is conditional on the Dhule plant executing on schedule and delivering the projected revenue uplift from FY28. The earnings call on April 20 at 4 PM will be important for Dhule commissioning updates and FY27 production volume guidance.

For more Q4 FY26 results analysis, visit Univest Blogs.

Frequently Asked Questions

1. What was Madhya Bharat Agro Products’ Q4 FY26 net profit?

MBAPL reported standalone Q4 FY26 net profit of ₹59.76 crore — up 319.4% year-on-year from ₹14.25 crore in Q4 FY25. The sharp growth reflects both volume expansion and the low base effect of Q4 FY25.

2. What was MBAPL’s FY26 full-year revenue and profit?

MBAPL’s FY26 standalone revenue was ₹1,866.98 crore (+76.3% YoY from ₹1,059.17 crore). Net profit was ₹150.18 crore (+161.3% YoY from ₹57.48 crore). The FY26 investor presentation reports record revenue of ₹1,867 crore and PAT of ₹150 crore.

3. What dividend did MBAPL declare for FY26?

The board of directors recommended a final dividend of ₹0.50 per equity share (5% on face value), subject to shareholder approval at the AGM. This is the first dividend recommendation of FY26.

4. What is the Dhule plant project update?

The Dhule (Maharashtra) greenfield plant — with 3,30,000 TPY DAP/NPK, 66,000 TPY phosphoric acid, and 3,96,000 TPY sulphuric acid — is targeted for commissioning in October 2026. Total project cost is approximately ₹550 crore. When operational, it is expected to add over 50% to FY27 revenue (management guidance described as “conservative”).

5. What is MBAPL’s current manufacturing capacity?

As of March 31, 2026, MBAPL’s total capacity is 3,30,000 MTPA following the addition of 90,000 MTPA at the Sagar facility (₹107 crore investment) commissioned March 31, 2026. Post-Dhule commissioning in October 2026, total group capacity will reach approximately 16 lakh MTPA across all products.

6. What products does Madhya Bharat Agro Products manufacture?

MBAPL manufactures Single Super Phosphate (SSP), DAP/NPK complex fertilizers, sulphuric acid, phosphoric acid, and beneficiated rock phosphate. It is part of the Ostwal Group and operates primarily in Bhilwara, Rajasthan, and Sagar, Madhya Pradesh.

7. When do TCS announce Q4 results 2026?

TCS declared Q4 FY26 results on April 9, 2026.

8. Is MBAPL a good investment after Q4 results?

MBAPL’s growth trajectory is exceptional, but the stock at ~32x trailing earnings has already priced in significant execution expectations. The Dhule plant commissioning in October 2026 is the next major catalyst. Sector risks include raw material price volatility (sulphur, rock phosphate), monsoon-dependent demand, and subsidy policy changes. Consult a SEBI-registered financial advisor before investing.

Disclaimer: Investment in the share market is subject to risk. This article is for informational and educational purposes only and does not constitute investment advice. All financial data is sourced from publicly available NSE/BSE filings and company investor relations pages. Verify all numbers before investing. Consult a SEBI-registered advisor before making investment decisions.

Recent Article

Natural Capsules Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook

National Fertilizers Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook

National Aluminium Company Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook

Nath Bio-Genes (India) Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook

Narmada Agrobase Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook